会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE THREATMENT OF ACHROMATOPSIA AND OTHER DISEASES
    • 促销剂,表达CASSETTES,矢车菊,搭便车及其他疾病的治疗方法
    • WO2014186160A1
    • 2014-11-20
    • PCT/US2014/036792
    • 2014-05-05
    • APPLIED GENETIC TECHNOLOGIES CORPORATION
    • YE, Guo-Jie
    • A61K48/00
    • A61K48/00A61K48/0058C12N15/86C12N2750/14141C12N2830/008
    • The present invention provides isolated promoters, transgene expression cassettes, vectors, kits, and methods for treatment of genetic diseases that affect the cone cells of the retina. The present invention features, in a first aspect, a nucleic acid comprising a portion of the cone cell specific promoter PR 2.1. In one embodiment, the nucleic acid comprises the sequence SEQ ID NO: 4. In another embodiment, PR2.1 is truncated at the 5' or the 3' end. In one embodiment of the above aspects, the promoter is capable of promoting CNGB3 expression in S-cone cells, M-cone cells, and L-cone cells. In another embodiment of the above aspects, the promoter is capable of promoting CNGA3 expression in S-cone cells, M-cone cells, and L-cone cells. In yet another embodiment of the above aspects, the promoter is capable of promoting GNAT2 expression in S-cone cells, M-cone cells, and L-cone cells.
    • 本发明提供分离的启动子,转基因表达盒,载体,试剂盒和用于治疗影响视网膜的锥细胞的遗传疾病的方法。 在第一方面,本发明的特征在于包含一部分锥细胞特异性启动子PR 2.1的核酸。 在一个实施方案中,核酸包含序列SEQ ID NO:4。在另一个实施方案中,PR2.1在5'或3'末端截短。 在上述方面的一个实施方案中,启动子能够促进S-锥细胞,M锥细胞和L-锥细胞中的CNGB3表达。 在上述方面的另一个实施方案中,启动子能够促进S-锥细胞,M-锥细胞和L-锥细胞中的CNGA3表达。 在上述方面的另一个实施方案中,启动子能够促进S锥体细胞,M锥细胞和L-锥细胞中的GNAT2表达。